CAMBRIDGE, Mass., Feb. 8, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced plans to release its financial results for
the fourth quarter and full-year 2020 ended December 31, 2020, on Thursday, February 25, 2021, before the opening
of the financial markets.
Akebia will host a conference call at 9:00 a.m. Eastern Time on Thursday, February 25,
2021 to discuss its fourth quarter and full-year 2020 financial
results and recent business highlights. To listen to the conference
call, please dial (877) 458-0977 (domestic) or (484) 653-6724
(international) using conference ID number 5455117. The call will
also be webcast live and can be accessed via the Investors section
of the Company's website at http://ir.akebia.com.
A replay of the conference call will be available two hours
after the completion of the call through March 3, 2021. To access the replay, dial (855)
859-2056 (domestic) or (404) 537-3406 (international) and reference
conference ID number 5455117. An online archive of the conference
call can be accessed via the Investors section of the Company's
website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Investor Contact
Kristen K.
Sheppard, Esq
ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-and-discuss-recent-business-highlights-301223576.html
SOURCE Akebia Therapeutics